Tandem Diabetes Care TNDM Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's other accrued liabilities?
- Tandem Diabetes Care (TNDM) reported other accrued liabilities of $84.1M in Q1 2026.
- How has Tandem Diabetes Care's other accrued liabilities changed year-over-year?
- Tandem Diabetes Care's other accrued liabilities decreased by 8.4% year-over-year, from $91.81M to $84.1M.
- What is the long-term trend for Tandem Diabetes Care's other accrued liabilities?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's other accrued liabilities has grown at a 34.1% compound annual growth rate (CAGR), from $17.34M to $75.24M.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.